Understanding Chronic Liver Disease: Causes, Symptoms, Treatment and Prevention

Chronic liver disease is a broad term for several conditions that can cause ongoing liver injury or damage over months or years. Because the liver can often continue working despite significant damage, a chronic liver condition may progress quietly before noticeable symptoms develop. Over time, repeated injury can lead to scar tissue formation (fibrosis). If the scarring becomes extensive, cirrhosis can develop and, in some cases, eventually lead to liver failure.

Long-term liver disease is not rare. The conditions that cause it affect millions of people in the United States, although its prevalence varies considerably by the underlying disease. For example, metabolic dysfunction-associated steatotic liver disease (MASLD)—formerly known as nonalcoholic fatty liver disease (NAFLD)—is among the most common forms of liver disease. Historical estimates from the National Institute of Diabetes and Digestive and Kidney Diseases indicate NAFLD affects about 24% of U.S. adults. More recent research suggests that approximately 2.4% of U.S. adults have compensated advanced chronic liver disease, which includes advanced fibrosis and cirrhosis, and many are unaware they have it.

What Is Chronic Liver Disease?

Chronic liver disease refers to ongoing liver damage caused by one or more conditions that affect the liver over an extended period. Unlike acute liver injury, which develops suddenly, chronic disease persists and can gradually change the liver’s structure and ability to function.

The liver performs hundreds of essential tasks, including processing nutrients, removing harmful substances from the blood, producing proteins involved in blood clotting and making bile to help digest fats. When liver cells are repeatedly injured, the body attempts to repair the damage. This healing response can create scar tissue. If the source of injury continues, fibrosis may become more extensive and eventually progress to cirrhosis.

Chronic liver disease is not one specific diagnosis or a single stage of illness. Rather, it describes a wide range of conditions and degrees of liver damage. Some patients may have an underlying liver condition with little or no fibrosis, while others may have advanced scarring and complications. Also, the course of disease is not always linear. Treating or controlling the underlying cause may slow or stop further damage and, in some situations, allow earlier fibrosis to improve.

This distinction can be especially important because chronic liver disease may cause few symptoms in its earlier stages. Abdominal swelling or unexplained changes in weight can occur with advanced disease, but these symptoms alone do not always indicate chronic liver disease. Confirming the diagnosis requires a medical evaluation that may involve blood tests, imaging and tests that assess liver scarring.

Factors that can influence whether progressive liver disease worsens include its underlying cause, how long the liver has been injured, the amount of existing fibrosis, alcohol use, metabolic conditions and how well the underlying disease responds to treatment. Identifying liver damage before it becomes advanced can provide more opportunities to address its cause and reduce the risk of complications.

Is Chronic Liver Disease the Same as Cirrhosis?

No. Chronic liver disease and cirrhosis are related, but they are not the same.

Chronic liver disease is a broader term for ongoing conditions that injure the liver. Cirrhosis is an advanced stage of liver scarring that can develop after prolonged or repeated injury. In cirrhosis, extensive scar tissue replaces healthy tissue, changes the liver’s structure and interferes with normal liver function and blood flow.

A patient can therefore have long-term liver disease without having cirrhosis. Depending on the condition and its treatment, liver damage may remain stable or progress from inflammation and injury to fibrosis and then cirrhosis. Not everyone with chronic liver disease will reach these advanced stages.

Cirrhosis itself also has different phases. In compensated cirrhosis, the liver is extensively scarred but can still perform many essential functions, and the patient may have few or no symptoms. Decompensated cirrhosis occurs when the damaged liver can no longer compensate effectively and complications develop, such as fluid buildup in the abdomen (ascites), internal bleeding from enlarged veins (varices), jaundice or problems with thinking and alertness (hepatic encephalopathy).

As cirrhosis advances, it can lead to liver failure, also known as end-stage liver disease. At that point, a liver transplant evaluation may become an important part of care for an eligible patient.

What Causes Chronic Liver Disease?

Chronic liver disease develops when a health condition or repeated exposure continues to injure the liver over time. Common causes include metabolic liver disease, long-term viral hepatitis and alcohol-associated liver disease. Autoimmune disorders, diseases of the bile ducts, certain inherited conditions and some medications also can cause ongoing liver damage.

Although these conditions may affect the liver in different ways, many can set off a cycle of injury, inflammation and healing. With persistent injury, scar tissue may accumulate and lead to fibrosis. Continued damage can eventually result in cirrhosis and, in advanced cases, liver failure. Some patients have more than one source of liver injury, which can influence how a chronic liver condition progresses.

Common Causes of Long-Term Liver Damage

Conditions and exposures that can lead to long-term liver disease include:

  • Metabolic dysfunction-associated steatotic liver disease – MASLD involves excess fat accumulation in the liver associated with metabolic risk factors. It is particularly common among people who are overweight or obese or have type 2 diabetes or metabolic syndrome. Some patients develop metabolic dysfunction-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), which involves liver inflammation and can progress to fibrosis and cirrhosis.
  • Chronic viral hepatitis – Hepatitis B and hepatitis C are viral infections that can become chronic and cause persistent liver inflammation and damage. Over time, chronic hepatitis B or C can lead to cirrhosis and other serious complications.
  • Alcohol-associated liver disease – Drinking excessive amounts of alcohol can damage liver cells. Alcohol-associated liver disease encompasses a spectrum of injury, ranging from fat accumulation in the liver to inflammation and cirrhosis. Alcohol also can contribute to the progression of liver damage caused by other conditions.
  • Autoimmune liver disease – Autoimmune hepatitis occurs when the immune system mistakenly attacks liver cells, causing chronic inflammation. Without effective treatment, the disease can progress to cirrhosis and liver failure.
  • Bile duct disease – Conditions that damage, destroy or obstruct the bile ducts can interfere with the normal movement of bile and cause liver injury. These include primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC).
  • Inherited liver diseases – Genetic conditions can affect how the liver processes or stores certain substances. Examples include hereditary hemochromatosis, which can cause excess iron to accumulate in the body, Wilson’s disease, which causes excess copper to accumulate, and alpha-1 antitrypsin deficiency. These conditions can cause progressive liver disease in some cases.
  • Medication-related liver damage – Certain medications, herbal products and dietary supplements can cause liver injury in some people. If drug-induced liver injury is suspected, a healthcare provider can determine whether a medication should be changed or discontinued.
  • Other medical conditions – Less commonly, conditions that interfere with blood flow through the liver, including chronic heart failure with liver congestion, may cause ongoing liver damage.

Chronic liver disease does not progress the same way in every patient. Identifying and treating the underlying condition may reduce ongoing injury and help prevent or slow further scarring. For example, hepatitis C often can be cured with antiviral therapy, while treatment can suppress hepatitis B and control inflammation from autoimmune hepatitis.

What Are the Risk Factors for Chronic Liver Disease?

Risk factors for chronic liver disease vary based on the underlying cause. Certain factors can increase the likelihood of developing a chronic liver condition, while others can worsen existing liver damage. Having one or more risk factors does not necessarily mean an individual will develop progressive liver disease.

Factors associated with an increased risk of long-term liver disease include:

  • Obesity and metabolic health conditions – Excess body weight, type 2 diabetes, high blood pressure, abnormal cholesterol or triglyceride levels and metabolic syndrome are associated with a higher risk of MASLD. Type 2 diabetes and obesity are also associated with a greater risk of developing more advanced forms of the disease, including fibrosis and cirrhosis.
  • Heavy or prolonged alcohol use – Regularly drinking excessive amounts of alcohol can injure liver cells and increase the risk of alcohol-associated liver disease. Alcohol also may worsen liver damage caused by another condition.
  • Exposure to a hepatitis virus – Hepatitis B and C can become chronic and cause ongoing liver injury. The risk varies by virus and is associated with factors such as contact with infected blood, sharing needles or other drug-injection equipment, unprotected sexual contact and transmission of hepatitis B from mother to baby during childbirth. Hepatitis C also may have been acquired through blood transfusions or organ transplants performed before widespread screening of the U.S. blood supply began in 1992.
  • Certain medications and supplements – Some prescription and over-the-counter medications, herbal remedies and dietary supplements can damage the liver. Taking multiple medications or having an existing liver condition may affect how safely certain substances are processed.
  • Family history and genetics – An inherited condition such as hereditary hemochromatosis, Wilson’s disease or alpha-1 antitrypsin deficiency can cause long-term liver damage. A family history of certain liver diseases may indicate a need for additional evaluation or testing.
  • Autoimmune disease – Certain autoimmune conditions can increase the likelihood of developing autoimmune liver or bile duct diseases, including autoimmune hepatitis and primary biliary cholangitis.
  • Conditions affecting the bile ducts – Diseases that cause chronic inflammation, narrowing or damage within the bile ducts can interfere with bile flow and eventually injure the liver. For example, PSC is strongly associated with inflammatory bowel disease, particularly ulcerative colitis.

Age also can influence the likelihood that years of liver injury have resulted in significant scarring. However, chronic liver disease can affect people at many stages of life, and some inherited, autoimmune and metabolic liver conditions can occur in younger people.

Risk factors do not determine how quickly liver disease will progress. The underlying cause, severity of existing liver damage, other medical conditions and response to treatment all can influence the disease course. Recognizing modifiable risk factors and identifying liver disease early may provide opportunities to prevent additional injury and reduce the likelihood of advanced liver disease.

What Are the Potential Complications of Chronic Liver Disease?

Chronic liver disease can lead to progressive liver scarring and complications if the damage continues over time. The specific risks depend on the cause of the liver disease, how much fibrosis is present and whether treatment can control the underlying source of injury. Not everyone with a chronic liver condition will develop cirrhosis or liver failure.

That said, some conditions, including MASH, chronic hepatitis B and C, alcohol-associated liver disease, autoimmune hepatitis, PBC and PSC, can cause persistent liver injury. Over time, that injury may lead to fibrosis and eventually cirrhosis.

Once cirrhosis develops, extensive scarring can interfere with liver function and blood flow through the liver. Potential complications of advanced chronic liver disease include:

  • Portal hypertension – Scarring can make it harder for blood to flow through the liver, increasing pressure in the portal vein, which carries blood from digestive organs to the liver. Portal hypertension can contribute to several other complications of cirrhosis.
  • Ascites and swelling – Portal hypertension and changes in liver function can cause fluid to accumulate in the abdomen. Fluid also may build up in the legs, ankles and feet.
  • Enlarged veins and internal bleeding – Increased pressure in the portal vein can cause varices to develop in the esophagus or stomach. If these veins rupture, they can cause serious, potentially life-threatening bleeding.
  • Hepatic encephalopathy – When a severely damaged liver cannot adequately remove certain toxins from the blood, those substances can affect the brain. The patient may experience confusion, changes in behavior, problems with concentration or, in severe cases, loss of consciousness.
  • Infection – Individuals with advanced cirrhosis can be more susceptible to infection. Ascites also can become infected, a complication known as spontaneous bacterial peritonitis.
  • Kidney problems – Advanced cirrhosis can impair kidney function. In severe cases, the patient may develop hepatorenal syndrome, a serious form of kidney dysfunction associated with advanced liver disease.
  • Bleeding and bruising problems – The liver produces proteins needed for normal blood clotting. As liver function declines, the patient may bruise or bleed more easily.
  • Malnutrition and muscle loss – Advanced liver disease can interfere with how the body processes and stores nutrients. Poor appetite and other complications also may contribute to weight loss, weakness and loss of muscle mass.
  • Liver cancer – Cirrhosis increases the risk of hepatocellular carcinoma, the most common type of primary liver cancer. Certain individuals with chronic hepatitis B also have an increased risk even without cirrhosis. Those at increased risk may require regular liver cancer screening.
  • Liver failure – With extensive damage, the liver may no longer be able to perform essential functions adequately. This advanced stage is known as liver failure or end-stage liver disease. In some cases, liver transplantation may ultimately be considered.

How Liver Disease Progresses Over Time

Progressive liver disease generally involves increasing amounts of scar tissue, but the course and speed of the progression can vary considerably from person to person.

When the liver is repeatedly injured, the body’s repair response can produce fibrous scar tissue. In its earlier stages, fibrosis does not necessarily prevent the liver from functioning normally and may improve if the underlying cause of liver injury is successfully treated or controlled.

If the injury continues, scar tissue can accumulate and alter the liver’s normal structure. Advanced, widespread scarring—cirrhosis—is generally considered permanent, although treating the cause of liver disease can prevent or slow further damage and, in some cases, lead to improvement in liver scarring.

A patient with compensated cirrhosis may have few symptoms because the liver is still able to perform many of its essential functions. Cirrhosis becomes decompensated when complications such as ascites, variceal bleeding, hepatic encephalopathy or jaundice develop. Decompensation is an important change in the course of chronic liver disease and generally indicates more advanced liver dysfunction.

As liver function continues to decline, the patient may develop end-stage liver disease. At this stage, treatment focuses on managing complications, addressing the underlying cause when possible and determining whether liver transplant evaluation is appropriate. Because disease progression is not the same for every patient, ongoing monitoring is essential to assess liver function, detect complications and adjust treatment as the condition changes.

What Are the Warning Signs and Symptoms of Chronic Liver Disease?

Chronic liver disease may cause few or no noticeable symptoms in its early stages. As the liver damage progresses and the organ has more difficulty performing its normal functions, symptoms may become more apparent. 

Chronic liver disease symptoms can vary based on the underlying condition, the extent of the liver damage and whether complications such as cirrhosis or portal hypertension have developed. Early and less specific symptoms may include:

  • Fatigue or weakness
  • Loss of appetite
  • Nausea
  • Unexplained weight loss
  • Discomfort in the upper right side of the abdomen
  • Itchy skin

It is important to note that these symptoms can have many causes other than liver disease. For example, fatigue, nausea and appetite changes can occur with numerous health conditions. While having one or more of these symptoms does not necessarily mean a chronic liver condition is present, any persistent or unexplained changes should be discussed with a healthcare provider.

As progressive liver disease becomes more advanced, signs and symptoms may include:

  • Jaundice – A buildup of bilirubin can cause the skin and whites of the eyes to appear yellow. Urine also may become darker.
  • Abdominal swelling – Fluid can accumulate in the abdomen, causing it to become noticeably larger or feel uncomfortable or tight.
  • Swelling in the legs, ankles or feet – Changes in blood flow and liver function can contribute to fluid buildup in the lower body.
  • Easy bruising or bleeding – Reduced production of proteins involved in blood clotting can make bruising or bleeding occur more easily.
  • Confusion or changes in alertness – Hepatic encephalopathy can cause difficulty concentrating, forgetfulness, confusion, personality or behavior changes or excessive sleepiness.
  • Muscle loss and weakness – Advanced liver disease can affect nutrition and metabolism, contributing to loss of muscle mass and physical strength.
  • More pronounced loss of appetite and weight loss – Poor appetite and difficulty maintaining adequate nutrition can become more significant as liver disease advances.

Age, overall health and coexisting medical conditions can influence how the symptoms of chronic liver disease appear. The underlying cause matters as well. Some liver diseases may produce symptoms related to the specific condition in addition to symptoms caused by declining liver function. Because the liver can continue functioning despite substantial injury, the severity of the symptoms does not always indicate how much liver damage is present. Regular monitoring can therefore be important even when the patient feels well.

Certain symptoms can signal a serious complication of advanced liver disease and require prompt medical attention. Vomiting blood, passing black or bloody stools or experiencing severe or rapidly worsening confusion, extreme drowsiness or loss of consciousness may indicate a medical emergency. These symptoms can occur with complications such as internal bleeding or severe hepatic encephalopathy and warrant immediate emergency medical care.

New or worsening jaundice, rapidly increasing abdominal swelling, fever with abdominal pain or significant changes in mental function also require prompt medical evaluation. Individuals with known chronic liver disease should talk with their healthcare provider about which changes to watch for and when to seek urgent or emergency care.

How Is Chronic Liver Disease Diagnosed?

Chronic liver disease is diagnosed through an evaluation of the patient’s medical history, symptoms, physical examination findings, laboratory test results and imaging studies. Because long-term liver disease may not cause obvious symptoms until significant damage has occurred, it is sometimes discovered through abnormal blood test results or imaging performed for an unrelated reason.

No single test is appropriate for every patient. The diagnostic process typically aims to identify the cause of the liver injury, determine how well the liver is functioning and assess whether fibrosis, cirrhosis or other complications are present. Testing may include:

  • Blood tests – Blood tests can measure liver enzymes and substances that reflect liver function, such as bilirubin and albumin. The healthcare team also may order tests for hepatitis B or C, autoimmune liver disease, inherited conditions or other possible causes of liver damage.
  • Ultrasound – An abdominal ultrasound uses sound waves to create images of the liver and nearby structures. It may show changes in the liver’s appearance, fat accumulation, signs of cirrhosis or complications, such as ascites.
  • Elastography – Tests such as FibroScan use noninvasive technology to measure liver stiffness, which can help estimate the amount of fibrosis. Some imaging centers also use ultrasound-based or magnetic resonance elastography to evaluate liver stiffness.
  • Computed tomography (CT) or magnetic resonance imaging (MRI) – These imaging tests can provide detailed views of the liver and surrounding structures. They may help identify changes associated with advanced liver disease and evaluate abnormalities or complications that require further investigation.
  • Liver biopsy – A liver biopsy involves removing a small sample of liver tissue for examination under a microscope. It can provide information about inflammation, fibrosis and certain causes of liver disease. A biopsy is not necessary for every patient because blood tests and noninvasive fibrosis assessments can often provide much of the information needed to evaluate chronic liver disease.
  • Additional tests – Depending on the suspected cause of chronic liver disease, the healthcare team may recommend specialized blood tests, genetic testing or procedures that evaluate the bile ducts and blood vessels around the liver.

How Is Liver Fibrosis Measured?

Liver fibrosis testing helps healthcare providers estimate how much scar tissue has developed and determine whether liver disease is progressing. In addition to elastography, the results from routine blood tests can be used to calculate noninvasive fibrosis scores. These assessments may help distinguish patients who are unlikely to have advanced fibrosis from those who need additional testing or specialist evaluation.

Fibrosis is generally described in stages ranging from little or no scarring to advanced fibrosis and cirrhosis. The exact staging system depends on the test and underlying liver condition. Results are considered alongside other clinical information rather than interpreted in isolation.

For a patient with an established chronic liver condition, repeating certain blood tests, fibrosis assessments or imaging studies over time can help the healthcare team monitor for changes and complications.

What Is the Model for End-Stage Liver Disease (MELD) Score?

The MELD score is used for patients with advanced chronic liver disease rather than as a general test for diagnosing liver disease. It is calculated from laboratory results that reflect liver and kidney function and other important clinical factors.

MELD 3.0 is the current MELD score used for adults awaiting liver transplantation in the United States. A higher score generally indicates a greater risk of death without a transplant and is one factor used to prioritize candidates for deceased-donor livers.

The MELD score does not determine on its own whether the patient needs or qualifies for a liver transplant. The healthcare team will consider the patient’s score along with complications of liver disease, overall health and other clinical factors. If liver disease becomes advanced, these findings can help determine when referral to a liver transplant center should become part of the care plan.

How Is Chronic Liver Disease Treated?

Treatment for chronic liver disease focuses on addressing the underlying cause, preventing or slowing further liver damage and managing complications. The most appropriate approach can vary depending on the type of liver disease, the amount of fibrosis or cirrhosis present, the patient’s overall health and how well the liver is functioning. Additionally, treatment may change as the disease progresses.

  • Treating the underlying cause – Treatment is tailored to the cause of liver damage. Antiviral medications can cure most cases of hepatitis C, while medications for chronic hepatitis B can suppress the virus and reduce the risk of further liver damage. Medications also can control autoimmune hepatitis and help manage certain bile duct diseases.
  • Making lifestyle changes – For a patient with MASLD, reaching and maintaining a healthy body weight through nutrition and physical activity can reduce liver fat and may improve inflammation and fibrosis. Alcohol avoidance is especially important for individuals with alcohol-associated liver disease and may be recommended for those with other forms of chronic liver disease.
  • Protecting the liver from additional injury – The healthcare team may review prescription and over-the-counter medications, vitamins and supplements to identify substances that could harm the liver or may need to be adjusted as liver function changes.
  • Treating complications of cirrhosis – Medications and procedures may be used to control fluid buildup, reduce the risk of bleeding from varices, manage hepatic encephalopathy or treat infections.
  • Monitoring for liver cancer – A patient with cirrhosis or certain other high-risk liver conditions may need regular surveillance for hepatocellular carcinoma. This monitoring can help detect liver cancer at an earlier stage, when more treatment options may be available.
  • Considering liver transplantation – When end-stage liver disease cannot be adequately managed with other treatments, liver transplantation may be an option for an eligible patient.

Regular follow-up care is also an important part of liver disease management. Periodic blood tests, imaging and other assessments can help the healthcare team continually evaluate liver function, monitor fibrosis and identify complications that may require changes in treatment.

Can Chronic Liver Disease Be Reversed?

Whether chronic liver disease can be reversed depends on its cause and how far the damage has progressed. In many cases, treating the underlying condition can stop or reduce ongoing liver injury. Earlier stages of fibrosis may improve when the source of damage is successfully addressed. For example, curing hepatitis C, controlling hepatitis B or autoimmune hepatitis, stopping alcohol use and addressing metabolic risk factors can help prevent additional liver damage. The degree of improvement can vary from patient to patient and by the underlying condition.

Advanced cirrhosis is generally not considered fully reversible because extensive scarring has significantly altered the liver’s structure. However, treating the cause can still be beneficial. It may slow or prevent further progression, reduce the risk of complications and, in some patients, improve liver function. A patient with cirrhosis will generally require continued monitoring even when the underlying cause has been successfully treated.

When Would a Liver Transplant Evaluation Be Considered for Chronic Liver Disease?

A liver transplant evaluation may be considered if chronic liver disease becomes advanced and the liver can no longer perform its essential functions adequately or if serious complications develop despite appropriate treatment. A referral for evaluation does not necessarily mean the patient will need or receive a transplant. Instead, an evaluation allows a transplant team to determine whether transplantation may be an appropriate treatment option and, when possible, plan before the disease becomes critically severe.

Factors that may prompt the healthcare team to consider referral to a liver transplant center include:

  • Development of decompensated cirrhosis, such as ascites, variceal bleeding or hepatic encephalopathy
  • Worsening liver function despite treatment
  • A MELD score that indicates increasing severity of liver disease
  • Recurrent or difficult-to-control complications
  • Certain liver cancers that meet criteria for transplantation

During the transplant evaluation, a multispecialty team will assess the severity of the liver disease as well as the patient’s heart and lung health, kidney function, nutritional status and other factors that could affect transplant surgery and recovery. The evaluation will also consider the patient’s medications, psychosocial health and the support available before and after transplantation.

Timing can be important. The patient does not need to be in liver failure before a transplant specialist becomes involved. Referral at an appropriate stage can provide the transplant team sufficient time to complete testing, address potentially modifiable health concerns and determine whether and when placement on the transplant waiting list may be appropriate.

What Is the Prognosis and Long-Term Outlook for Chronic Liver Disease?

The outlook for chronic liver disease can vary widely. Some liver conditions can be successfully treated or controlled for many years, particularly when they are identified before extensive scarring develops. Other forms of progressive liver disease may eventually lead to cirrhosis, serious complications or end-stage liver disease. The patient’s prognosis will depend on factors such as the cause of the liver damage, the amount of fibrosis present, whether cirrhosis has developed, other health conditions and how well the disease responds to treatment.

Early diagnosis and appropriate treatment can make an important difference. Addressing the underlying cause may slow or stop additional liver injury and, in some cases, allow fibrosis to improve. Even after cirrhosis develops, treatment and regular monitoring can help reduce the risk of further progression and allow complications to be identified and managed.

A patient living with a chronic liver condition can take an active role in their long-term care. Depending on their individual needs, the healthcare team may recommend:

  • Keeping regular medical appointments – Follow-up visits can allow the healthcare team to monitor liver function, evaluate changes in fibrosis and adjust treatment when needed.
  • Taking medications as directed – Following the prescribed treatment plan can help control the underlying liver condition and manage complications.
  • Avoiding substances that may cause additional liver injury – The patient should follow their healthcare team’s guidance about alcohol use and discuss any prescription medications, over-the-counter drugs, vitamins and supplements.
  • Supporting good nutrition and physical health – Nutritional needs can change as liver disease advances. The healthcare team or a dietitian can recommend an eating plan based on the patient’s condition and help address concerns such as unintended weight loss or muscle loss.
  • Completing recommended screening and surveillance – Depending on the type and stage of liver disease, ongoing care may include blood tests, imaging, endoscopy or liver cancer screening.
  • Reporting new or worsening symptoms – Changes such as increasing abdominal swelling, jaundice, confusion, bleeding or significant changes in weight or appetite may indicate that liver disease or one of its complications is worsening.

For a patient with compensated cirrhosis, the liver may continue to perform its essential functions for years, although ongoing medical care will remain important. The outlook can change if cirrhosis becomes decompensated and complications such as ascites, variceal bleeding or hepatic encephalopathy occur. At that point, closer monitoring and treatment will generally be needed, and a liver transplant evaluation may become part of the long-term care plan.

There is no single timeline for chronic liver disease. Regular monitoring can help the healthcare team understand how the patient’s condition is changing over time, address complications and determine whether more advanced treatment should be considered.

What Are the Possible Mental, Emotional and Social Effects of Chronic Liver Disease on Daily Life?

Living with chronic liver disease can affect more than physical health. Uncertainty about whether the disease will progress, the need for ongoing medical care and symptoms such as fatigue can affect emotional well-being, relationships, work and everyday activities. These effects can vary considerably based on the severity of the disease and the patient’s individual circumstances. Possible challenges include:

  • Stress, anxiety or fear – The patient may worry about disease progression, future complications, medical testing or the possibility of eventually needing a liver transplant.
  • Changes in mood – Coping with a long-term health condition can contribute to sadness, frustration or other changes in emotional well-being. In advanced liver disease, hepatic encephalopathy also can cause changes in mood, behavior, concentration and thinking.
  • Fatigue and reduced stamina – Persistent tiredness or weakness may make it more difficult to work, exercise, complete household tasks or participate in social activities.
  • Changes in independence – Complications of advanced liver disease may make some daily activities more difficult and increase the need for assistance from family members, friends or other caregivers.
  • Work and financial concerns – Medical appointments, symptoms and periods of illness may interfere with employment. Frequent medical care also can create practical and financial concerns for some patients and families.
  • Effects on relationships and social life – Dietary changes, avoiding alcohol use, reduced energy and frequent medical care may affect routines with family and friends. Changes in thinking or behavior related to hepatic encephalopathy also can be challenging for the patient and their caregivers.
  • Concerns about appearance and body changes – Jaundice, abdominal swelling, swelling in the legs or muscle loss can affect how the patient feels about their appearance and may make some social situations uncomfortable.

The patient does not have to manage these challenges alone. Depending on their needs, support may come from physicians, nurses, dietitians, social workers, behavioral health professionals, transplant specialists and other members of the care team. Family members and caregivers also can play an important role, particularly when advanced liver disease affects a person's thinking, mobility or ability to manage medical care.Talking openly with the healthcare team about emotional and practical concerns can help connect the patient and their family with appropriate resources while supporting quality of life throughout treatment.

Can Chronic Liver Disease Be Prevented?

Not every case of chronic liver disease can be prevented. Inherited and autoimmune liver diseases, for example, may develop for reasons that cannot be controlled. However, certain steps can reduce the risk of some causes of long-term liver disease or help prevent additional damage when a chronic liver condition is already present.

Ways to protect liver health may include:

  • Limiting or avoiding alcohol consumption – Drinking less alcohol can reduce the risk of alcohol-associated liver disease. Individuals who already have liver disease should ask their healthcare provider whether they need to avoid alcohol completely.
  • Maintaining a healthy body weight – Reaching and maintaining a weight that supports overall health can reduce the risk of MASLD and related liver damage. Regular physical activity and a balanced eating pattern also can support metabolic health.
  • Managing metabolic conditions – Controlling diabetes, high blood pressure and abnormal cholesterol or triglyceride levels can help address factors associated with MASLD.
  • Preventing viral hepatitis – Vaccines can prevent hepatitis A and B. There is currently no vaccine for hepatitis C, but avoiding contact with infected blood, not sharing needles or other drug-injection equipment and following recommended screening guidelines can help reduce risks associated with viral hepatitis.
  • Using medications and supplements safely – Taking medications according to the directions and discussing over-the-counter drugs, vitamins and supplements with a healthcare provider can help reduce the risk of medication-related liver injury.
  • Getting tested when appropriate – Hepatitis B and C and some other liver conditions can be present without noticeable symptoms. Recommended screening can help identify certain causes of chronic liver disease before advanced damage develops.
  • Following treatment for an existing liver condition – For an individual who already has liver disease, taking prescribed medications, attending follow-up appointments and completing recommended monitoring can help limit further injury and identify complications.

Preventive care also depends on risk factors. An individual with a family history of inherited liver disease, risk factors for viral hepatitis or metabolic conditions associated with MASLD may benefit from discussing liver health with a healthcare provider even when no symptoms are present.

While prevention is not always possible, identifying and addressing liver injury early can help reduce the likelihood that progressive liver disease will advance to cirrhosis, liver failure or other serious complications.

The TGH Difference for Chronic Liver Disease

Chronic liver disease can range from an early, manageable condition to advanced cirrhosis and end-stage liver disease. Because the disease course is different for every patient, care may need to evolve over time. Identifying the cause, monitoring liver damage and addressing complications can help preserve liver function for as long as possible. When liver disease becomes advanced, timely evaluation can help determine whether liver transplantation should be considered.

At Tampa General Hospital, patients with chronic or advanced liver disease have access to specialized care through the Comprehensive Liver Disease & Transplant Center at the TGH Transplant Institute. Physicians from multiple specialties work together to care for patients with chronic liver disease, complications of cirrhosis, alcohol-associated liver disease, liver tumors and other complex liver and biliary conditions. Our center also helps patients understand their medical management options and determine whether a transplant evaluation may be appropriate.

For patients who need transplantation, TGH offers both deceased-donor and living-donor liver transplantation. The TGH liver transplant program began in 1987 and has performed more than 3,000 liver transplants. In 2025 alone, TGH performed 284 liver transplants as part of a record 895 transplants across its Transplant Institute.

TGH also provides access to nationally recognized gastrointestinal expertise. In Newsweek's 2026 list of America’s Best Hospitals for Specialized Care, Tampa General ranked No. 48 nationally for gastrointestinal care. TGH was the only health system in Tampa recognized across all seven specialties included in the 2026 rankings.

Whether you were recently diagnosed with a chronic liver condition or are managing complications of advanced disease, personalized medical guidance can help clarify what comes next. Contact Tampa General Hospital to learn more about chronic liver disease care or request an evaluation with a specialist.